US Broker Ratings

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a 61% Potential Upside and Strong Buy Ratings

For investors with a penchant for the biotechnology sector, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) presents an intriguing opportunity marked by substantial growth potential and robust market positioning. With a market..

McKesson Corporation (MCK) Investor Outlook: Analyzing a 14.85% Upside Potential

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, stands as a titan in the medical distribution industry with a market capitalization of $102.02 billion. As investors seek resilient..

Repligen Corporation (RGEN) Stock Analysis: A Closer Look at Its 17.59% Potential Upside and Growth Trajectory

Repligen Corporation (NASDAQ: RGEN) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $9.14 billion, the company..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Unpacking a Promising 28% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a leading player in the biotechnology sector, has captured investor attention with a market capitalization of $10.25 billion and a promising potential upside of 28.29%...

HCA Healthcare, Inc. (HCA) Stock Analysis: Growth Momentum Amidst Analyst Optimism

HCA Healthcare, Inc. (NYSE: HCA) stands as a significant player in the U.S. healthcare industry, commanding a robust market capitalization of $110.18 billion. Specializing in medical care facilities, HCA operates..

Medtronic plc (MDT) Stock Analysis: Strong Buy Signals Amidst a 9.24% Upside Potential

Medtronic plc (MDT), a titan in the healthcare sector, specifically in the medical devices industry, has garnered attention with its substantial market capitalization of $129.39 billion. As an Ireland-based company,..

Humana Inc. (HUM) Stock Analysis: Examining Growth Potential Amidst Healthcare Sector Dynamics

For investors navigating the healthcare sector, Humana Inc. (NYSE: HUM) presents a compelling opportunity. As a key player in the healthcare plans industry, Humana commands a substantial market presence in..

Alkermes plc (ALKS) Stock Analysis: Exploring a Promising 29.98% Potential Upside

Alkermes plc (NASDAQ: ALKS), a biopharmaceutical company headquartered in Dublin, Ireland, is garnering attention from investors due to its robust product pipeline and impressive potential upside of nearly 30%. Operating..

Option Care Health, Inc. (OPCH) Stock Analysis: Promising Potential with a 6.02% Upside

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, stands out as a significant provider of home and alternate site infusion services across the United States...

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth with a 4.35% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector focusing on animal health, has captured investor attention with its impressive market cap of $12.12 billion and..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Exploring a 15% Potential Upside with Robust Revenue Growth

BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands out in the healthcare sector as a promising player in the biotechnology industry. With its innovative approach to developing transformative medicines for genetic diseases..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 14.34% Upside in the Global Eye Care Market

Alcon Inc. (NYSE: ALC), a leading player in the healthcare sector, focuses on pioneering eye care solutions that span the globe. As a key entity in the Medical Instruments &..

Tempus AI, Inc. (TEM) Stock Analysis: A Healthcare Tech Powerhouse with 34.59% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM) stands at the forefront of innovation in the healthcare sector, leveraging cutting-edge technology to deliver advanced diagnostic and analytical solutions. With a market capitalization of..

GSK plc (GSK) Investor Outlook: Evaluating a 5.75% Upside Potential in the Healthcare Giant

GSK plc (GSK), a venerable name in the healthcare sector, stands as a formidable player within the global drug manufacturing industry. With a market capitalization of $99.33 billion, this United..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Marvel with 16% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND) stands out in the biotechnology sector with its innovative approach to addressing unmet medical needs through TransCon-based therapies. As the healthcare industry continues to evolve,..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating Growth in the Diagnostics Sector with a 4.25% Upside

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a formidable entity in the healthcare sector, particularly within the Diagnostics & Research industry. With a market capitalization of $235.19 billion, this..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a 4.66% Potential Upside Amidst Industry Challenges

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a significant player in the global pharmaceutical industry, offering a diverse portfolio that spans across generic medications, active pharmaceutical ingredients, and innovative..

DaVita Inc. (DVA) Investor Outlook: Unpacking a 32% Potential Upside Amidst Healthcare Challenges

DaVita Inc. (NYSE: DVA), a leading player in the healthcare sector, specifically within the medical care facilities industry, presents a mixed yet intriguing opportunity for investors. With a market capitalization..

Cooper Companies, Inc. (COO) Investor Outlook: Navigating a 12% Upside Potential in Healthcare

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, has garnered significant attention from investors seeking opportunities in the medical instruments and supplies industry. Headquartered in..

Revvity, Inc. (RVTY) Stock Analysis: Navigating the Healthcare Diagnostics Landscape with a $13.55 Billion Market Cap

Revvity, Inc. (RVTY), a stalwart in the healthcare diagnostics and research industry, offers a diverse range of health sciences solutions, technologies, and services. With a market capitalization of $13.55 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds